Susceptibility of carbapenem-resistant Klebsiella pneumoniae in urinary tract infections: clinical efficacy of fosfomycin
The Journal of Infection in Developing Countries · 28.02.2026 · 20 (02) · 237-245
DOI: 10.3855/jidc.21257 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 28.02.2026. Verfasst von Arda Kaya und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey. Hauptthemen laut MEDLINE: Fosfomycin, Urinary Tract Infections, Anti-Bacterial Agents, Klebsiella pneumoniae. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The increasing prevalence of carbapenem-resistant Klebsiella pneumoniae (CR-Kp) limits effective treatment options. The aim of this study was to evaluate the susceptibility patterns of CR-Kp strains isolated from urine cultures to oral treatment options recommended by the Infectious Diseases Society of America guidelines, and ceftazidime-avibactam. Additionally, clinical data and outcomes of patients diagnosed with CR-Kp urinary tract infections (UTI) who were treated with fosfomycin sodium-including therapy regimens (FSITR) were analyzed. Methodology: This retrospective cohort study included adult patients with urine culture-proven CR-Kp between March 2016 and October 2022. Demographic and clinical data, antibiotic susceptibility, treatment outcomes, and one-month mortality (OMM) were evaluated.
Results
A total of 179 patients were included. The susceptibility to fosfomycin tromethamol, nitrofurantoin, and co-trimoxazole (TMP-SMX) were (33.7%; 55/163), (7.7%; 13/167), and (11.1%; 20/179), respectively. All strains were resistant to ciprofloxacin. The susceptibility data compared until 2020 (pre-COVID-19) and afterwards, revealed TMP-SMX susceptibility (4.9% vs 24.1%, p = 0.0001) increased significantly. Susceptibility data for ceftazidime-avibactam were available for 22 isolates and 59% of the isolates were sensitive. OMM of the 179 patients with CR-Kp in urine cultures was 37.4% (67/179). There were 9 FSITR cases. Among those, microbiological eradication was achieved in 87.5% (7/8) and OMM was 44.4% (4/9).
Conclusions
Clinical experience may be feasible and needed to assess the efficacy of nitrofurantoin and TMP-SMX. Fosfomycin-including regimens may serve as a salvage treatment option for CR-Kp UTI in selected patients. However, the retrospective and single-center design of the study should be considered as a limitation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
- Department of Medical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
- Faculty of Medicine, Ege University, Izmir, Turkey.
- Department of Pulmonology, Faculty of Medicine, Ege University, Izmir, Turkey.
- Department of Neurosurgery, Faculty of Medicine, Ege University, Izmir, Turkey.
- Department of Internal Medicine, Faculty of Medicine, Ege University, Izmir, Turkey.
Zitieren
APA
Kaya, A., Akyol-Seyhan, D., Chousein-Memetali, S., Yaşar, M., Mert-Vahabi, M., Başkol-Elik, D., Dirik, Ş., Şanlıdağ-İşbilen, G., Bulut-Avşar, C., Demir-Görür, M., Guliyeva, G., Uyan-Önal, A., Önal, U., Yalçın, N., Kenanoğlu, B., Yeniyol, Ş., Dağ, D., Korkmaz, P., Özgiray, E., …, & Sipahi, O. R. (2026). Susceptibility of carbapenem-resistant Klebsiella pneumoniae in urinary tract infections: clinical efficacy of fosfomycin. The Journal of Infection in Developing Countries, 20(02), 237-245. https://doi.org/10.3855/jidc.21257
Vancouver
Kaya A, Akyol-Seyhan D, Chousein-Memetali S, Yaşar M, Mert-Vahabi M, Başkol-Elik D, et al. Susceptibility of carbapenem-resistant Klebsiella pneumoniae in urinary tract infections: clinical efficacy of fosfomycin. The Journal of Infection in Developing Countries. 2026;20(02):237-245. doi:10.3855/jidc.21257
BibTeX
@article{Kaya2026,
author = {Kaya, Arda and Akyol-Seyhan, Deniz and Chousein-Memetali, Seichan and Yaşar, Melike and Mert-Vahabi, Merve and Başkol-Elik, Dilşah and Dirik, Şükrü and Şanlıdağ-İşbilen, Gamze and Bulut-Avşar, Cansu and Demir-Görür, Melike and Guliyeva, Gunel and Uyan-Önal, Ayşe and Önal, Uğur and Yalçın, Nazlıhan and Kenanoğlu, Buse and Yeniyol, Şevket and Dağ, Deniz and Korkmaz, Pervin and Özgiray, Erkin and Bozkurt, Devrim and Şirin, Hadiye and Çınar, Ece and Demirağ, Kubilay and Sipahi, Hilal and Çilli, Feriha and Aydemir, Şöhret and Taşbakan, Meltem and Erdem, Hüseyin A and Pullukçu, Hüsnü and Yamazhan, Tansu and Ulusoy, Sercan and Arda, Bilgin and Sipahi, Oğuz R},
title = {Susceptibility of carbapenem-resistant Klebsiella pneumoniae in urinary tract infections: clinical efficacy of fosfomycin},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {02},
pages = {237--245},
doi = {10.3855/jidc.21257}
}
EUVIMED